CCDC79 Inhibitors

Compounds like Olaparib and Mitomycin C can affect the DNA repair pathways, potentially altering the function of proteins like CCDC79, which may be involved in this process. Similarly, Camptothecin and Etoposide, as topoisomerase inhibitors, can result in DNA damage that requires the involvement of DNA repair proteins. Inhibitors such as Nocodazole and Roscovitine act upon cell division and cycle regulation processes, which can influence the activity and regulation of proteins that play roles in mitosis and cell cycle checkpoints.

Trichostatin A represents inhibitors that can change chromatin dynamics and gene expression, thereby influencing proteins that regulate these processes. Autophagy inhibitors like Chloroquine can affect cellular degradation pathways, impacting the function of proteins associated with lysosomal degradation. Bortezomib, a proteasome inhibitor, can lead to the accumulation of proteins, affecting protein turnover and associated regulatory mechanisms. Hydroxyurea and Aphidicolin act by disrupting DNA synthesis, which can influence proteins involved in nucleotide metabolism and DNA replication.